KM
Korenberg Matthew E
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Korenberg Matthew E, Chief Financial Officer. Insider active across 2 companies, notably Ligand Pharmaceuticals INC. Cumulatively, 25 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €2m. History available since 30 June 2021. The latest transaction was disclosed on 20 September 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Korenberg Matthew E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
19,506 sharesCommon StockSEC:0001005286-25-000090:0
4,982 shares@ US$49.995.9% of flowCommon StockSEC:0002001011-24-000087:0
914 shares@ US$55.751.2% of flowCommon StockSEC:0002001011-24-000082:0
1,157 shares@ US$105.542.9% of flowCommon StockSEC:0002001011-24-000078:0
24,554 sharesCommon StockSEC:0001628280-24-038088:0
18,245 shares@ US$98.5043.3% of flowCommon StockSEC:0002001011-24-000071:0
350 shares@ US$60.7070.5% of flowCommon StockSEC:0002001011-24-000064:0
3,440 shares@ US$84.54317.1% of flowCommon StockSEC:0002001011-24-000052:0
14,416 shares0Common StockSEC:0002001011-24-000029:0
4,778 shares@ US$74.658.7% of flowCommon StockSEC:0002001011-24-000018:0
2,917 shares@ US$72.315.0% of flowCommon StockSEC:0002001011-24-000009:0
1,984 shares@ US$59.612.9% of flowCommon StockSEC:0002001011-23-000003:0
376 shares@ US$56.780.5% of flowCommon StockSEC:0000886163-23-000045:0
9,069 shares0Common StockSEC:0000899243-23-006297:0
2,890 shares@ US$72.985.2% of flowCommon StockSEC:0000899243-23-005552:0
3,859 shares@ US$66.296.3% of flowCommon StockSEC:0000899243-22-039583:0
14,000 shares0Common StockSEC:0000899243-22-038699:0
3,593 shares@ US$72.906.7% of flowCommon StockSEC:0000899243-22-037330:0
27,714 shares0Common StockSEC:0000899243-22-035047:0
164 shares@ US$75.8370.3% of flowCommon StockSEC:0000886163-22-000107:0
8,062 shares0Common StockSEC:0000886163-22-000090:0
906 shares@ US$123.682.6% of flowCommon StockSEC:0000886163-22-000021:0
4,803 shares0Common StockSEC:0000886163-22-000014:0
247 shares@ US$85.90950.5% of flowCommon StockSEC:0000886163-21-000097:0
3,870 sharesCommon StockSEC:0000886163-16-000144:0
About Korenberg Matthew E
Korenberg Matthew E is Directeur Financier. He has 25 filings in total, and the 25 sampled filings run from 2016-02-16 to 2025-07-17. In this recent sample, purchases are EUR 0 and sales are EUR 2025656, with activity mainly in Ligand Pharmaceuticals INC and LIFECORE BIOMEDICAL, INC. \DE\; the modal transaction nature is Attribution.